Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.20.2
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 103,101 $ 50,364
Trading account assets, pledged as collateral 110,698 90,946
Debt securities:    
Held-to-maturity, fair value 347,917 219,821
Loans and leases, measured at fair value 7,234 8,335
Loans held for sale, measured at fair value 1,905 3,709
Other assets, measured at fair value 12,725 15,518
Deposits in U.S. offices:    
Interest bearing, measured at fair value 626 508
Federal funds purchased and securities loaned or sold under agreements to repurchase, measured at fair value 132,322 16,008
Short-term borrowings, measured at fair value 4,577 3,941
Accrued expenses and other liabilities, measured at fair value 12,765 15,434
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,910 813
Long-term debt, measured at fair value $ 30,455 $ 34,975
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,887,440 3,887,440
Preferred stock outstanding (in shares) 3,887,440 3,887,440
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 8,661,522,562 8,836,148,954
Common stock outstanding (in shares) 8,661,522,562 8,836,148,954
Consolidated VIEs | Short-term borrowings    
Shareholders’ equity    
Non-recourse debt $ 25 $ 0
Consolidated VIEs | Long-term debt    
Shareholders’ equity    
Non-recourse debt 5,742 8,717
Consolidated VIEs | Other liabilities    
Shareholders’ equity    
Non-recourse debt $ 19 $ 19